Markets:

Overview

News

Currencies

International

Treasuries

Lyell Immunopharma, Inc. - Common Stock (NQ:LYEL)

15.00 -0.43 (-2.79%)

Delayed Quote Updated: 4:00 PM EST, Nov 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Lyell Immunopharma, Inc. - Common Stock

< Previous 1 2 3 Next >

Today's US Session Top Gainers and Losers: TNONW and CENN Lead ↗

November 04, 2026

Via Chartmill

Top U.S. Stock Movers: Nov. 4, 2026 Gainers and Losers ↗

November 04, 2026

Via Chartmill

US Gap Movers for Nov. 4, 2026: Sharp Opens in Both Directions ↗

November 04, 2026

Via Chartmill

Lyell Immunopharma Targets 2027 FDA Filing as CAR-T Pipeline Advances ↗

May 27, 2026

Lyell Immunopharma (NASDAQ:LYEL) President and CEO Lynn Seely outlined the company’s clinical development priorities, regulatory strategy and manufacturing plans during a Stifel investor session...

Via MarketBeat

The Analyst Verdict: Lyell Immunopharma In The Eyes Of 4 Experts ↗

November 12, 2024

Via Benzinga

The market is filled with gapping stocks in Wednesday's session. ↗

February 18, 2026

Via Chartmill

Foresite Capital Goes Bullish on Cytokinetics (CYTK), Snapping Up 458K Shares ↗

December 08, 2025

Foresite Capital Goes Bullish on Cytokinetics (CYTK), Snapping Up 458K Shares

Via The Motley Fool

Topics Regulatory Compliance

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 10, 2025

Via Benzinga

This United Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday ↗

September 26, 2025

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings...

Via Benzinga

Lyell Immunopharma Inc (NASDAQ:LYEL) Reports Q2 2025 Earnings Beat with Clinical Progress on LYL314 ↗

August 12, 2025

Lyell Immunopharma reports Q2 2025 with a narrower loss than expected, driven by cost controls. Clinical progress for CAR T-cell therapy LYL314 remains strong, with pivotal trials advancing. Cash...

Via Chartmill

Topics Earnings

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 31, 2025

Via Benzinga

Applied Materials To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

June 24, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 05, 2025

Via Benzinga

Here are the top movers in Thursday's session. ↗

June 05, 2025

Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

What's going on in today's session ↗

June 04, 2025

Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes.

Via Chartmill

What's going on in today's session ↗

March 19, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top gainers and losers in today's session.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 19, 2025

Via Benzinga

Lyell Immunopharma Downgraded, Analyst Flags Concerns Over Acquisition Strategy ↗

October 30, 2024

Lyell Immunopharma acquires ImmPACT Bio, ends TIL programs, and refocuses on CAR T-cell research. Analyst downgrades reflect concerns over pipeline complexities.

Via Benzinga

Why Deckers Outdoor Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗

October 25, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 24, 2024

Via Benzinga

ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins fuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday ↗

August 19, 2024

Via Benzinga

LYEL Stock Earnings: Lyell Immunopharma Beats EPS for Q2 2024 ↗

August 08, 2024

LYEL stock results show that Lyell Immunopharma beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

3 Biotech Stocks to Sell in August Before They Crash & Burn ↗

August 06, 2024

Investors should keep a watchful eye out for these three biotech stocks to sell before a potential dip damages their gains.

Via InvestorPlace

Lyell Immunopharma Shares Plunge On One Patient Death In CAR-T Cell Therapy Cancer Trial ↗

June 26, 2024

Lyell Immunopharma shares fell following the release of initial clinical data from its Phase 1 trial of LYL797, a reprogrammed CAR T-cell product. The company reported some severe cases reported in...

Via Benzinga

LYEL Stock Earnings: Lyell Immunopharma Beats EPS for Q1 2024 ↗

May 06, 2024

LYEL stock results show that Lyell Immunopharma beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Live Nation Entertainment, Groupon And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

April 16, 2024

U.S. stock futures were mixed this morning, with the Dow futures gaining around 100 points on Tuesday.

Via Benzinga

Topics Stocks

Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 12, 2024

Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.

Via Benzinga

Argan Reports Upbeat Earnings, Joins Coupang And Other Big Stocks Moving Higher On Friday ↗

April 12, 2024

U.S. stocks were lower, with the Dow Jones index falling over 250 points on Friday. Shares of Argan, Inc. (NYSE: AGX) rose sharply during Friday’s session as the company reported better-than-expected...

Via Benzinga

Topics Stocks

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

April 12, 2024

Friday is here and we're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers this morning!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 11, 2024

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.